Cochlear Given Underperform Rating at Credit Suisse (COH)
Cochlear (ASX:COH)‘s stock had its “underperform” rating restated by investment analysts at Credit Suisse in a note issued to investors on Sunday, AmericanBankingNews.com reports.
Shares of Cochlear (ASX:COH) opened at 58.550 on Friday. Cochlear has a one year low of A$52.710 and a one year high of A$82.870. The stock has a 50-day moving average of A$58.85 and a 200-day moving average of A$63.13. The company has a market cap of A$3.332 billion and a price-to-earnings ratio of 25.33.
A number of other firms have also recently commented on COH. Analysts at Bank of America Corp. reiterated an “underperform” rating on shares of Cochlear in a research note to investors on Wednesday, October 9th. Four research analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of A$70.54 ($68.49).
Cochlear Limited (ASX:COH) is an Australia-based company, which operates in the implantable hearing device industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.